Caprolactone acrylate(CAS: 110489-05-9)

Caprolactone acrylate (CAS: 110489-05-9) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulations in the EU, and the Toxic Substances Control Act (TSCA) in the USA. It is also regulated by the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) in terms of its use and handling.

Caprolactone acrylate (CAS: 110489-05-9) can be synthesized as an alternative to other acrylate esters. Common alternatives include methyl acrylate, ethyl acrylate, and butyl acrylate. Other esters such as glycidyl methacrylate or styrene are also viable options depending on the specific application requirements.

The market for Caprolactone acrylate (CAS: 110489-05-9) is growing due to its use in the production of biocompatible polymers for medical implants and tissue engineering. Research trends are focusing on developing new applications in pharmaceuticals and advanced coatings. Additionally, there is increasing interest in sustainable and biodegradable materials, which is driving innovation in this field.

Waste containing Caprolactone acrylate (CAS: 110489-05-9) should be collected in appropriate containers and disposed of by a licensed waste management company. It is advisable to incinerate the waste under controlled conditions or use professional waste disposal services to ensure compliance with environmental protection regulations. Proper storage and transportation of the waste are also crucial to prevent environmental contamination.